AMPHENOL CORPORATION

(APH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 32 08939 12052 30441 752--
Enterprise Value (EV)1 34 78741 28555 90645 11244 36343 793
P/E ratio 28,9x33,4x34,4x24,6x22,6x20,6x
Yield 0,89%0,80%0,73%1,15%1,20%1,20%
Capitalization / Revenue 3,90x4,55x4,81x3,45x3,27x3,05x
EV / Revenue 4,23x4,80x5,14x3,73x3,48x3,20x
EV / EBITDA 17,8x21,1x21,7x15,8x14,5x13,3x
Price to Book 7,36x7,47x8,68x6,12x5,36x4,50x
Nbr of stocks (in thousands) 592 983598 310598 028597 139--
Reference price (USD) 54,165,487,569,969,969,9
Announcement Date 01/22/202001/27/202101/26/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 8 2258 59910 87612 10912 76513 685
EBITDA1 1 9571 9582 5712 8493 0683 289
Operating profit (EBIT)1 1 6451 6502 1762 4462 6122 803
Operating Margin 20,0%19,2%20,0%20,2%20,5%20,5%
Pre-Tax Profit (EBT)1 1 4961 5271 9892 3472 5362 725
Net income1 1 1551 2031 5911 7761 9162 075
Net margin 14,0%14,0%14,6%14,7%15,0%15,2%
EPS2 1,881,962,542,843,093,39
Dividend per Share2 0,480,520,640,810,840,84
Announcement Date 01/22/202001/27/202101/26/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 2 8193 0272 9522 9333 0633 177
EBITDA1 666729681687717749
Operating profit (EBIT)1 571608590590623648
Operating Margin 20,3%20,1%20,0%20,1%20,3%20,4%
Pre-Tax Profit (EBT)1 542564563562601626
Net income1 427454426424454474
Net margin 15,1%15,0%14,4%14,5%14,8%14,9%
EPS2 0,680,740,680,680,730,76
Dividend per Share ------
Announcement Date 10/27/202101/26/202204/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 2 6982 1653 6033 3602 6112 041
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,38x1,11x1,40x1,18x0,85x0,62x
Free Cash Flow1 1 2071 3151 1801 7522 0312 069
ROE (Net Profit / Equities) 27,0%24,3%27,2%26,7%25,7%24,6%
Shareholders' equity1 4 2744 9585 8436 6647 4478 442
ROA (Net Profit / Asset) 11,1%10,4%11,8%11,7%11,8%12,1%
Assets1 10 43011 57113 50315 14716 28817 152
Book Value Per Share2 7,368,7610,111,413,015,5
Cash Flow per Share2 2,442,592,463,003,604,15
Capex1 295277360404443521
Capex / Sales 3,59%3,22%3,31%3,34%3,47%3,81%
Announcement Date 01/22/202001/27/202101/26/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 41 751 925 598
Net sales (USD) 10 876 300 000
Number of employees 90 000
Sales / Employee (USD) 120 848
Free-Float 99,2%
Free-Float capitalization (USD) 41 402 753 566
Avg. Exchange 20 sessions (USD) 183 941 911
Average Daily Capital Traded 0,44%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA